Haploidentical DLI for relapse post haplo bone marrow transplantation with high- dose of cyclophosphamide post-transplant as GvHD prophylaxis: is it feasible?

被引：0
|
作者：
Ghiso, A. [1 ]
Raiola, A. M. [1 ]
Gualandi, F. [1 ]
Dominietto, A. [1 ]
Varaldo, R. [1 ]
van Lint, M. T. [1 ]
Bregante, S. [1 ]
di Grazia, C. [1 ]
Lamparelli, T. [1 ]
Lucchetti, S. [1 ]
Geroldi, S. [1 ]
Bacigalupo, A. [1 ]
机构：
[1] S Martinos Hosp, Genoa, Italy
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [1] Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis
    Ghiso, Anna
    Raiola, Annamaria
    Gualandi, Francesca
    Dominietto, Alida
    Varaldo, Riccardo
    van Lint, Maria Teresa
    Bregante, Stefania
    Di Grazia, Carmen
    Lamparelli, Teresa
    Luchetti, Silvia
    Geroldi, Simona
    Tedone, Elisabetta
    Bacigalupo, Andrea P.
    [J]. BLOOD, 2012, 120 (21)
  • [2] Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation
    Fuji, Shigeo
    Sugita, Junichi
    Najima, Yuho
    Konishi, Tatsuya
    Tanaka, Takashi
    Ohigashi, Hiroyuki
    Eto, Tetsuya
    Nagafuji, Koji
    Hiramoto, Nobuhiro
    Matsuoka, Ken-ichi
    Maruyama, Yumiko
    Ota, Shuichi
    Ishikawa, Jun
    Kawakita, Toshiro
    Akasaka, Takashi
    Kamimura, Tomohiko
    Hino, Masayuki
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Yakushijin, Kimikazu
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (03) : 959 - 966
  • [3] Post-Relapse Survival after Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post Transplant Cyclophosphamide (PTCY): Potential Impact of DLI Post-Relapse
    Solh, Melhem
    Bashey, Asad
    Solomon, Scott R.
    Morris, Lawrence E.
    Zhang, Xu
    Holland, H. Kent
    [J]. BLOOD, 2021, 138
  • [4] Impact of HLA disparity on GvHD and relapse rate in haploidentical transplants followed by high dose post-transplant cyclophosphamide
    Raiola, A. M.
    Sacchi, N.
    Garbarino, L.
    Bregante, S.
    DiGrazia, C.
    Dominietto, A.
    Giannoni, L.
    Gualandi, F.
    Lamparelli, T.
    Marani, C.
    Vanlint, M. T.
    Varaldo, R.
    Ibatici, A.
    Bacigalupo, A.
    Angelucci, E.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S44 - S45
  • [5] Impact of HLA disparity on GvHD and relapse rate in haploidentical transplants followed by high dose post-transplant cyclophosphamide
    Raiola, A. M.
    Sacchi, N.
    Garbarino, L.
    Giannoni, L.
    Dominietto, A.
    Aquino, S.
    Beltrami, G.
    Bregante, S.
    Di Grazia, C.
    Gualandi, F.
    Ibatici, A.
    Lamparelli, T.
    Marani, C.
    van Lint, M. T.
    Varaldo, R.
    Bacigalupo, A.
    Angelucci, E.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 156 - 156
  • [6] NONMYELOABLATIVE HLA-HAPLOIDENTICAL BONE MARROW TRANSPLANTATION (HAPLO-BMT) WITH POST-TRANSPLANT HIGH-DOSE CYCLOPHOSPHAMIDE (CY) IN PATIENTS WITH SEVERE HEMOGLOBINOPATHIES
    Bolanos-Meade, J.
    Lanzkron, S.
    Kemberling, H.
    Gamper, C.
    Ambinder, R. F.
    Luznik, L.
    Luznik, E. J.
    Jones, R. J.
    Brodsky, R. A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S285 - S285
  • [7] Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for 41 Children and Adolescents with Bone Marrow Failures
    Bonfim, Carmem
    Ribeiro, Lisandro
    Nichele, Samantha
    Bitencourt, Marco
    Kuwahara, Cilmara
    Melo Rodrigues, Ana Luiza
    Loth, Gisele
    Pereira, Noemi F.
    Lima, Alberto C. M.
    Eapen, Mary
    Pasquini, Ricardo
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S74 - S75
  • [8] Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis in high risk hematologic malignancies: Bone Marrow vs Peripheral Blood Stem Cell comparison
    Gayoso, J.
    Balsalobre, P.
    Kwon, M.
    Lopez-Corral, L.
    Heras, I.
    Pinana, J. L.
    Pascual, M. J.
    Bermudez, A.
    Caballero, D.
    Herrera, P.
    Castilla-Llorente, C.
    Solano, C.
    Anguita, J.
    Jimenez, S.
    Bento, L.
    Perez-Simon, A.
    Martin, C.
    Humala, K.
    Champ, D.
    Laiglesia, A.
    Montesinos, P.
    Buno, I.
    Diez-Martin, J. L.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S157 - S158
  • [9] Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Post-Transplant Cyclophosphamide (PTCy) As GVHD Prophylaxis In High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
    Gayoso, J.
    Balsalobre, P.
    Kwon, M.
    Castilla-Llorente, C.
    Pascual, M. J.
    Serrano, D.
    Lopez-Corral, L.
    Pinana, J. L.
    Bermudez, A.
    Perez-Simon, J. A.
    Herrera, P.
    Montesinos, P.
    Ferra, C.
    Sampol, A.
    Anguita, J.
    Heras, I.
    Champ, D.
    Martinez-Laperche, C.
    Solano, C.
    Caballero, D.
    Diez-Martin, J. L.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S355 - S356
  • [10] NK cell reconstitution following unmanipulated haploidentical bone marrow transplant with high dose cyclophosphamide post-transplant
    Meazza, R.
    Pende, D.
    Raiola, A. M.
    Falco, M.
    Tuberosa, C.
    Loiacono, F.
    Dominietto, A.
    Mingari, M. C.
    Geroldi, S.
    Moretta, L.
    Ghiso, A.
    Bacigalupo, A.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S135 - S135
12345